drugset / Trial / NCT01847807
The Organ Protection of Astragalus in Subjects With Metabolic Syndrome
RandomizedParallel-groupSingle-blindTreatment
Summary
Metabolic syndrome have the damages on tissues and organs in heart、kindey and vessels. In this study, prospective randomized, controlled, parallel designed ,different doses of Astragalus Mongolia, Gansu Longxi produce treat on the MS patients, and then use real-time quantitative PCR and Western Blotting to detect the index of oxidative stress 、angiotensin-converting enzyme 2 mRNA expression and proteins.
Timeline
- Start
- 2011-01
- Primary completion
- 2015-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Astragalus | Traditional medicine (herbal / TCM) | 5 g | — |
| Comparator | Astragalus | Traditional medicine (herbal / TCM) | 10 g | — |